1-(环丙基甲基)环丙烷-1-磺酰胺

反应条件: temp:60.01; pressure:0.00; stir:; See reaction.notes.procedure_details.

实验步骤: CDI (27 mg, 0.17 mmol) was added to a stirring solution of 13-cyclohexyl-3-methoxy-6-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-7H-indolo[2,1-a][2]benzazepine-10-carboxylic acid trifluoroacetate (70 mg, 0.130 mmol)) in THF (0.5 mL) and the reaction mixture was heated at 60° C. for 1.5 h. The reaction was cooled to rt and then 1-(cyclopropylmethyl)cyclopropane-1-sulfonamide (29.6 mg, 0.169 mmol) was added. The reaction was stirred 5 min. and then DBU (0.029 mL, 0.195 mmol) was added. The reaction was stirred at rt for 1 h, more DBU (0.029 mL, 0.195 mmol) was added and stirred at rt ON (˜75% conversion by LCMS). The reaction was diluted with EtOAc (˜2 mL) and washed with 1M aq. HCl (2×2 mL). The organic layer was concentrated under a steam of nitrogen, dissolved into MeOH (˜3 mL) and purified by preparative HPLC (Column: Xterra Prep MS C18 5 u 30×100 mm, Eluent A: 5% acetonitrile/water with 10 mM ammonium acetate, Eluent B: 95% acetonitrile/water with 10 mM ammonium acetate, Flow Rate: 42 mL/min, linear gradient from 15% Eluent B to 100% Eluent B over 20 min) to yield 13-cyclohexyl-N-((1-(cyclopropylmethyl)cyclopropyl)sulfonyl)-3-methoxy-6-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-7H-indolo[2,1-a][2]benzazepine-10-carboxamide (32 mg, 0.046 mmol, 35% yield) as a yellow solid. 1H NMR (300 MHz, CDCl3) δ ppm 0.02-0.09 (m, 2H), 0.38-0.47 (m, 2H), 0.61-0.74 (m, 1H), 1.14-2.95 (m, 31H), 3.89 (s, 3H), 4.20-4.42 (m, 1H), 5.11-5.32 (m, 1H), 6.82 (s, 1H), 6.86-6.90 (m, 2H), 7.05 (dd, J=8.8, 2.6 Hz, 1H), 7.49 (d, J=8.8 Hz, 1H), 7.49-7.54 (m, 1H), 7.86 (d, J=8.4 Hz, 1H), 8.10 (br s, 1H). LC-MS retention time: 3.46 min; m/z 697 (MH+). LC data was recorded on a Shimadzu LC-10AS liquid chromatograph equipped with a Phenomenex-Luna 10 u C18 3.0×50 mm column using a SPD-10AV UV-Vis detector at a detector wave length of 220 nM. The elution conditions employed a flow rate of 5 mL/min, a gradient of 100% solvent A/0% solvent B to 0% solvent A/100% solvent B, a gradient time of 4 min, a hold time of 1 min, and an analysis time of 5 min where solvent A was 10% MeOH/90% H2O/0.1% trifluoroacetic acid and solvent B was 10% H2O/90% MeOH/0.1% trifluoroacetic acid. MS data was determined using a Micromass Platform for LC in electrospray mode. The reaction was cooled to rt The reaction was stirred at rt for 1 h stirred at rt ON (˜75% conversion by LCMS) washed with 1M aq. HCl (2×2 mL) The organic layer was concentrated under a steam of nitrogen dissolved into MeOH (˜3 mL) purified by preparative HPLC (Column: Xterra Prep MS C18 5 u 30×100 mm, Eluent A: 5% acetonitrile/water with 10 mM ammonium acetate, Eluent B: 95% acetonitrile/water with 10 mM ammonium acetate, Flow Rate: 42 mL/min, linear gradient from 15% Eluent B to 100% Eluent B over 20 min)

反应条件: temp:60.01; pressure:0.00; stir:; See reaction.notes.procedure_details.

实验步骤: CDI (27 mg, 0.17 mmol) was added to a stirring solution of 13-cyclohexyl-3-methoxy-6-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-7H-indolo[2,1-a][2]benzazepine-10-carboxylic acid trifluoroacetate (70 mg, 0.130 mmol)) in THF (0.5 mL) and the reaction mixture was heated at 60° C. for 1.5 h. The reaction was cooled to rt and then 1-(cyclopropylmethyl)cyclopropane-1-sulfonamide (29.6 mg, 0.169 mmol) was added. The reaction was stirred 5 min. and then DBU (0.029 mL, 0.195 mmol) was added. The reaction was stirred at rt for 1 h, more DBU (0.029 mL, 0.195 mmol) was added and stirred at rt ON (˜75% conversion by LCMS). The reaction was diluted with EtOAc (˜2 mL) and washed with 1M aq. HCl (2×2 mL). The organic layer was concentrated under a steam of nitrogen, dissolved into MeOH (˜3 mL) and purified by preparative HPLC (Column: Xterra Prep MS C18 5 u 30×100 mm, Eluent A: 5% acetonitrile/water with 10 mM ammonium acetate, Eluent B: 95% acetonitrile/water with 10 mM ammonium acetate, Flow Rate: 42 mL/min, linear gradient from 15% Eluent B to 100% Eluent B over 20 min) to yield 13-cyclohexyl-N-((1-(cyclopropylmethyl)cyclopropyl)sulfonyl)-3-methoxy-6-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-7H-indolo[2,1-a][2]benzazepine-10-carboxamide (32 mg, 0.046 mmol, 35% yield) as a yellow solid. 1H NMR (300 MHz, CDCl3) δ ppm 0.02-0.09 (m, 2H), 0.38-0.47 (m, 2H), 0.61-0.74 (m, 1H), 1.14-2.95 (m, 31H), 3.89 (s, 3H), 4.20-4.42 (m, 1H), 5.11-5.32 (m, 1H), 6.82 (s, 1H), 6.86-6.90 (m, 2H), 7.05 (dd, J=8.8, 2.6 Hz, 1H), 7.49 (d, J=8.8 Hz, 1H), 7.49-7.54 (m, 1H), 7.86 (d, J=8.4 Hz, 1H), 8.10 (br s, 1H). LC-MS retention time: 3.46 min; m/z 697 (MH+). LC data was recorded on a Shimadzu LC-10AS liquid chromatograph equipped with a Phenomenex-Luna 10 u C18 3.0×50 mm column using a SPD-10AV UV-Vis detector at a detector wave length of 220 nM. The elution conditions employed a flow rate of 5 mL/min, a gradient of 100% solvent A/0% solvent B to 0% solvent A/100% solvent B, a gradient time of 4 min, a hold time of 1 min, and an analysis time of 5 min where solvent A was 10% MeOH/90% H2O/0.1% trifluoroacetic acid and solvent B was 10% H2O/90% MeOH/0.1% trifluoroacetic acid. MS data was determined using a Micromass Platform for LC in electrospray mode. The reaction was cooled to rt The reaction was stirred at rt for 1 h stirred at rt ON (˜75% conversion by LCMS) washed with 1M aq. HCl (2×2 mL) The organic layer was concentrated under a steam of nitrogen dissolved into MeOH (˜3 mL) purified by preparative HPLC (Column: Xterra Prep MS C18 5 u 30×100 mm, Eluent A: 5% acetonitrile/water with 10 mM ammonium acetate, Eluent B: 95% acetonitrile/water with 10 mM ammonium acetate, Flow Rate: 42 mL/min, linear gradient from 15% Eluent B to 100% Eluent B over 20 min)

反应条件: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.

实验步骤: 2-(2,2-Dimethyl-5-oxo-[1,3]dioxolan-4-ylidene)-N-(4-fluoro-benzyl)-N-methoxy-acetamide was treated with 1-cyclopropylmethyl-cyclopropanesulfonic acid amide as described in the preparation of compound 1 to yield the title compound. MS (M−H) calcd for C19H22FN2O6S: 425.1. Found: 425.0. 1H NMR (500 MHz, CDCl3) δ: 0.12 (m, 2), 0.50 (m, 2), 0.70 (m, 1), 1.14 (m, 2), 1.75 (m, 2), 1.88 (m, 2), 3.69 (s, 3), 4.79 (s, 2), 6.54 (s, 1), 7.03 (m, 2), 7.30 (m, 2), 8.83 (s, 1). Anal calcd for C19H23FN2O6S; C, 53.51; H, 5.43; N, 6.56. Found: C, 53.43; H, 5.64; N, 6.51.

反应条件: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.

实验步骤: This compound was obtained in 65% yield from 1-cyclopropylmethylcyclopropylsulfonylamine tert-butylcarbamate (from Step B.2.a) according to the procedure described for the synthesis of 1-methoxymethylcyclopropylsulfonamide (Step B.1.b). The compound was purified by column chromatography over SiO2 using 0% to 60% ethyl acetate in hexanes as the eluent: 1H NMR (CDCl3) δ 0.15 (m, 2H), 0.51 (m, 2H), 1.01 (m, 2H), 1.34 (m, 3H), 1.86 (d, J=7.0 Hz, 2H), 4.83 (s, 2H); 13C NMR (CDCl3) δ 4.65, 7.74, 11.26, 35.62, 41.21; LRMS m/z 193 (M++NH4). The compound was purified by column chromatography over SiO2 using 0% to 60% ethyl acetate in hexanes as the eluent

反应条件: temp:60.01; pressure:0.00; stir:; See reaction.notes.procedure_details.

实验步骤: CDI (27 mg, 0.17 mmol) was added to a stirring solution of 13-cyclohexyl-3-methoxy-6-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-7H-indolo[2,1-a][2]benzazepine-10-carboxylic acid trifluoroacetate (70 mg, 0.130 mmol)) in THF (0.5 mL) and the reaction mixture was heated at 60° C. for 1.5 h. The reaction was cooled to rt and then 1-(cyclopropylmethyl)cyclopropane-1-sulfonamide (29.6 mg, 0.169 mmol) was added. The reaction was stirred 5 min. and then DBU (0.029 mL, 0.195 mmol) was added. The reaction was stirred at rt for 1 h, more DBU (0.029 mL, 0.195 mmol) was added and stirred at rt ON (˜75% conversion by LCMS). The reaction was diluted with EtOAc (˜2 mL) and washed with 1M aq. HCl (2×2 mL). The organic layer was concentrated under a steam of nitrogen, dissolved into MeOH (˜3 mL) and purified by preparative HPLC (Column: Xterra Prep MS C18 5 u 30×100 mm, Eluent A: 5% acetonitrile/water with 10 mM ammonium acetate, Eluent B: 95% acetonitrile/water with 10 mM ammonium acetate, Flow Rate: 42 mL/min, linear gradient from 15% Eluent B to 100% Eluent B over 20 min) to yield 13-cyclohexyl-N-((1-(cyclopropylmethyl)cyclopropyl)sulfonyl)-3-methoxy-6-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-7H-indolo[2,1-a][2]benzazepine-10-carboxamide (32 mg, 0.046 mmol, 35% yield) as a yellow solid. 1H NMR (300 MHz, CDCl3) δ ppm 0.02-0.09 (m, 2H), 0.38-0.47 (m, 2H), 0.61-0.74 (m, 1H), 1.14-2.95 (m, 31H), 3.89 (s, 3H), 4.20-4.42 (m, 1H), 5.11-5.32 (m, 1H), 6.82 (s, 1H), 6.86-6.90 (m, 2H), 7.05 (dd, J=8.8, 2.6 Hz, 1H), 7.49 (d, J=8.8 Hz, 1H), 7.49-7.54 (m, 1H), 7.86 (d, J=8.4 Hz, 1H), 8.10 (br s, 1H). LC-MS retention time: 3.46 min; m/z 697 (MH+). LC data was recorded on a Shimadzu LC-10AS liquid chromatograph equipped with a Phenomenex-Luna 10 u C18 3.0×50 mm column using a SPD-10AV UV-Vis detector at a detector wave length of 220 nM. The elution conditions employed a flow rate of 5 mL/min, a gradient of 100% solvent A/0% solvent B to 0% solvent A/100% solvent B, a gradient time of 4 min, a hold time of 1 min, and an analysis time of 5 min where solvent A was 10% MeOH/90% H2O/0.1% trifluoroacetic acid and solvent B was 10% H2O/90% MeOH/0.1% trifluoroacetic acid. MS data was determined using a Micromass Platform for LC in electrospray mode. The reaction was cooled to rt The reaction was stirred at rt for 1 h stirred at rt ON (˜75% conversion by LCMS) washed with 1M aq. HCl (2×2 mL) The organic layer was concentrated under a steam of nitrogen dissolved into MeOH (˜3 mL) purified by preparative HPLC (Column: Xterra Prep MS C18 5 u 30×100 mm, Eluent A: 5% acetonitrile/water with 10 mM ammonium acetate, Eluent B: 95% acetonitrile/water with 10 mM ammonium acetate, Flow Rate: 42 mL/min, linear gradient from 15% Eluent B to 100% Eluent B over 20 min)